COPD is a challenging disease that ultimately leads to a progressive reduction in lung function. Our mainstays of therapy are the bronchodilators like long-acting anticholinergic and long-acting beta-agonists. Roflumilast (podcast) is a unique medication for COPD in...
As a geriatric pharmacist, I understand how difficult it can be to manage polypharmacy and pain management. I had the honor of being invited onto the Pain Pod. This podcast is put together by Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS. We addressed many different...
Pharmacist reimbursement has been a frustrating battle for us pharmacists. We don’t get enough respect when it comes to legislation (i.e. provider status) and reimbursement of clinical services. There was a recent research article put out by the CDC that...
I’ve been doing quite a bit of long term care consulting lately and I’ve been trying to pay attention to which medications and medication classes I have been targeting in an effort to reduce polypharmacy. Here are my top 5 targets to reduce medications in...
Alpha-blockers (i.e., tamsulosin) are commonly seen in male patients, as they are used to treat symptoms of benign prostatic hyperplasia (BPH; the only FDA-approved indication currently). Because of this, there is no doubt a prescription sent to the pharmacy for a...
